Risk of gastric and oesophageal adenocarcinoma following discontinuation of long-term proton-pump inhibitor therapy

被引:0
|
作者
Holmberg, Dag [1 ,2 ]
Lagergren, Jesper [1 ,2 ,3 ]
机构
[1] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden
[2] Karolinska Univ Hosp, Stockholm, Sweden
[3] Kings Coll London, Sch Canc & Pharmaceut Sci, London, England
关键词
D O I
10.1007/s00535-022-01941-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:183 / 183
页数:1
相关论文
共 50 条
  • [41] Long-Term Use of Proton-Pump Inhibitors: Unravelling the Safety Puzzle
    Bhatnagar, Manish S.
    Choudhari, Sachin
    Pawar, Dattatray
    Sharma, Akhilesh
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (01)
  • [42] Proton-pump inhibitor therapy as a risk factor for gastric polyp development: A single center experience in a private hospital
    Lesmana, Cosmas Rinaldi Adithya
    Cahyadinata, Lidwina
    Pakasi, Levina S.
    Lesmana, Laurentius Adrianto
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 380 - 380
  • [43] Proton pump inhibitor - side effects and complications of long-term proton pump inhibitor administration
    Ueberschaer, Hendrik
    Allescher, Hans-Dieter
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (01): : 63 - 74
  • [44] Morphological changes of the human gastric mucosa under long-term proton pump inhibitor therapy and their clinical relevance
    Lamberts, R
    [J]. MICROSCOPY RESEARCH AND TECHNIQUE, 2000, 48 (06) : 357 - 366
  • [45] Risks versus benefits of long-term proton pump inhibitor therapy in the elderly
    Schuler, Amy
    [J]. GERIATRIC NURSING, 2007, 28 (04) : 225 - 229
  • [46] The relationship between long-term proton pump inhibitor therapy and skeletal frailty
    Lau, Arthur N.
    Tomizza, Michael
    Wong-Pack, Matthew
    Papaioannou, Alexandra
    Adachi, Jonathan D.
    [J]. ENDOCRINE, 2015, 49 (03) : 606 - 610
  • [47] Long-term proton pump inhibitor therapy and osteoporosis. Is there a real danger?
    Maleth Jozsef
    Hegyi Peter
    [J]. ORVOSI HETILAP, 2013, 154 (26) : 1005 - 1009
  • [48] The relationship between long-term proton pump inhibitor therapy and skeletal frailty
    Arthur N. Lau
    Michael Tomizza
    Matthew Wong-Pack
    Alexandra Papaioannou
    Jonathan D. Adachi
    [J]. Endocrine, 2015, 49 : 606 - 610
  • [49] Proton-Pump Inhibitor use and the risk of Ischaemic Stroke
    Dai, C.
    Jiang, M.
    Cao, Q.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2018, 283 (03) : 330 - 330
  • [50] Gastric protection or bone protection? The dilemma of proton-pump inhibitor
    del Pino Montes, J.
    [J]. REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2015, 7 (04) : 83 - 84